- Home
- ALLT vs VNDA Comparison
ALLT vs VNDA Comparison
Compare ALLT & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- VNDA
- Stock Information
- Founded
- ALLT 1996
- VNDA 2002
- Country
- ALLT Israel
- VNDA United States
- Employees
- ALLT N/A
- VNDA N/A
- Industry
- ALLT Telecommunications Equipment
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- VNDA Health Care
- Exchange
- ALLT Nasdaq
- VNDA Nasdaq
- Market Cap
- ALLT 229.8M
- VNDA 237.9M
- IPO Year
- ALLT 2006
- VNDA 2006
- Fundamental
- Price
- ALLT $8.34
- VNDA $3.91
- Analyst Decision
- ALLT Buy
- VNDA Strong Buy
- Analyst Count
- ALLT 1
- VNDA 2
- Target Price
- ALLT $13.00
- VNDA $16.50
- AVG Volume (30 Days)
- ALLT 321.2K
- VNDA 477.8K
- Earning Date
- ALLT 05-12-2025
- VNDA 05-07-2025
- Dividend Yield
- ALLT N/A
- VNDA N/A
- EPS Growth
- ALLT N/A
- VNDA N/A
- EPS
- ALLT N/A
- VNDA N/A
- Revenue
- ALLT $93,455,000.00
- VNDA $201,351,000.00
- Revenue This Year
- ALLT $6.43
- VNDA $14.36
- Revenue Next Year
- ALLT $5.83
- VNDA $44.53
- P/E Ratio
- ALLT N/A
- VNDA N/A
- Revenue Growth
- ALLT N/A
- VNDA 13.37
- 52 Week Low
- ALLT $2.02
- VNDA $3.85
- 52 Week High
- ALLT $9.44
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- ALLT 69.53
- VNDA 34.54
- Support Level
- ALLT $5.61
- VNDA $3.91
- Resistance Level
- ALLT $8.70
- VNDA $4.51
- Average True Range (ATR)
- ALLT 0.48
- VNDA 0.17
- MACD
- ALLT 0.27
- VNDA -0.04
- Stochastic Oscillator
- ALLT 78.76
- VNDA 4.10
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.